Transporting without infusions: effect on door-to-needle time for acute coronary syndrome patients.

Background: Standard of care for patients with acute coronary syndrome/ST-segment elevation myocardial infarction (ACS/STEMI) is rapid revascularization of ischemic myocardium. Current optimal treatment is primary percutaneous coronary intervention (PCI) within 90 minutes after the patient accesses the health care system, and strategies to lower this time may improve outcomes.

Objective: To compare interhospital transport times (TTs) before and after instituting a no-medication-infusion policy during transport of ACS patients.